Next Article in Journal
Optimization Co-Culture of Monascus purpureus and Saccharomyces cerevisiae on Selenium-Enriched Lentinus edodes for Increased Monacolin K Production
Previous Article in Journal
Ganoderma pfeifferi Bres. and Ganoderma resinaceum Boud. as Potential Therapeutic Agents: A Comparative Study on Antiproliferative and Lipid-Lowering Properties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Candida tropicalis PMT2 Is a Dispensable Gene for Viability but Required for Proper Interaction with the Host

by
Marco J. Hernández-Chávez
1,
Iván Martínez-Duncker
2,
Diana M. Clavijo-Giraldo
1,
Luz A. López-Ramirez
1 and
Héctor M. Mora-Montes
1,*
1
Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, C.P., Guanajuato 36050, GTO, Mexico
2
Laboratorio de Glicobiología Humana y Diagnóstico Molecular, Centro de Investigación en Dinámica Celular, Instituto de Investigación en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, MOR, Mexico
*
Author to whom correspondence should be addressed.
J. Fungi 2024, 10(7), 502; https://doi.org/10.3390/jof10070502
Submission received: 1 July 2024 / Revised: 17 July 2024 / Accepted: 18 July 2024 / Published: 20 July 2024
(This article belongs to the Section Fungal Cell Biology, Metabolism and Physiology)

Abstract

:
Candidemia is an opportunistic mycosis with high morbidity and mortality rates. Even though Candida albicans is the main causative agent, other Candida species, such as Candida tropicalis, are relevant etiological agents of candidiasis and candidemia. Compared with C. albicans, there is currently limited information about C. tropicalis’ biological aspects, including those related to the cell wall and the interaction with the host. Currently, it is known that its cell wall contains O-linked mannans, and the contribution of these structures to cell fitness has previously been addressed using cells subjected to chemical treatments or in mutants where O-linked mannans and other wall components are affected. Here, we generated a C. tropicalis pmt2∆ null mutant, which was affected in the first step of the O-linked mannosylation pathway. The null mutant was viable, contrasting with C. albicans where this gene is essential. The phenotypical characterization showed that O-linked mannans were required for filamentation; proper cell wall integrity and organization; biofilm formation; protein secretion; and adhesion to extracellular matrix components, in particular to fibronectin; and type I and type II collagen. When interacting with human innate immune cells, it was found that this cell wall structure is dispensable for cytokine production, but mutant cells were more phagocytosed by monocyte-derived macrophages. Furthermore, the null mutant cells showed virulence attenuation in Galleria mellonella larvae. Thus, O-linked mannans are minor components of the cell wall that are involved in different aspects of C. tropicalis’ biology.

1. Introduction

Candida spp. are yeast usually found as part of the microbiota of the gastrointestinal tract and urogenital system. In healthy populations, they are commensals but can transit to a pathogenic lifestyle, causing superficial infections of skin and nails, or even deep-seated mycosis in immunocompromised patients, such as systemic candidiasis [1]. Nosocomial bloodstream Candida infections are found worldwide and are a life-threatening disease with high mortality rates of up to 71% [2,3]. Even though Candida albicans is the most common etiological agent of systemic candidiasis, other Candida species are associated with the disease and represent a significant burden for health systems [3,4,5]. Candida tropicalis is part of the clinically relevant Candida species that affect immunocompromised patients. It is frequently isolated in tropical countries but distributed worldwide and is responsible for 33–48% of systemic candidiasis cases [6,7]. Moreover, the isolation frequency increased 1.4-fold in intensive care unit patients during the COVID-19 pandemic outbreak [8]. This is the most frequently isolated species in Pakistan and India [7], and the most common Candida species isolated from neutropenic patients [6].
One point in common among the medically relevant fungal species, except Cryptococcus spp., is that the cell wall is the outermost fungal structure, and consequently, the first in establishing interaction with the host cells and tissues [9,10,11,12]. Contrary to C. albicans, a thoroughly studied fungal species, the C. tropicalis cell wall has been poorly studied. It contains chitin, β-1,6- and β-1,3-glucans, and N-linked mannans [13,14,15]. This oligosaccharide is composed of a Man9GlcNAc2 N-linked mannan core modified with an α-1,6-polymannose outer chain, which contains lateral chains of α-1,2-mannose units [16]. These lateral chains may be further modified with β-1,2-mannose units or phosphomannan [16,17]. When compared to C. albicans, C. tropicalis has increased cell wall porosity but similar chitin, glucan, and mannan content [15]. Like other Candida species, the C. tropicalis cell wall contains O-linked mannans that are linear mannose-based oligosaccharides and are in similar abundance to those found in the C. albicans cell wall [15].
In C. albicans, both N-linked and O-linked mannans are relevant cell wall components for tissue adhesion, virulence, and sensing by host immunity [15,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34]. Studies on the role of C. tropicalis cell wall components during interaction with the host are scarce. This organism induces a stronger cytokine response by human peripheral blood mononuclear cells (PBMCs) than C. albicans in a dectin-1-dependent pathway when fungal cells are heat-killed, indicating a strong contribution of β-1,3-glucan sensing for cytokine stimulation [15]. Moreover, the phagocytosis of C. tropicalis by human monocyte-derived macrophages is higher than in C. albicans cells, involving a phosphomannan-dependent pathway [15]. Different from C. albicans, C. tropicalis induces fungipod formations in dendritic cells [17,35]. Mincle, a pattern recognition receptor that binds α-mannans contained in cell wall mannans, is dispensable for controlling systemic C. albicans infections but plays a role during systemic candidiasis caused by C. tropicalis [34]. In addition, it has been established that C. tropicalis O-linked mannans are dispensable for cytokine production by human PBMCs, but N-linked mannans and β1,3-glucan are essential to stimulate cytokine production via co-stimulation of both dectin-1 and mannose receptor [17], and N-linked mannans are required for proper biofilm formation in C. tropicalis [36].
Protein-O-mannosyltransferases (Pmts) are endoplasmic reticulum (ER) membrane-bound proteins that transfer mannose residues to the lateral chain of serine/threonine residues in a co- or posttranslational mechanism [37]. This enzyme activity starts the O-linked mannosylation pathway, which continues in the Golgi complex, where members of the MNT gene family extend the O-linked mannan to up to seven α-1,2-mannose units [23,38]. In C. albicans, five Pmts have been identified: Pmt1 and Pmt5 (belonging to the Pmt1 subfamily), Pmt2 and Pmt6 (members of the Pmt2 subfamily), and Pmt4 [39]. Currently, null mutants for PMT genes have been generated, except PMT2, which is essential and cannot be complemented by PMT6, the other subfamily member [39]. The heterozygous PMT2/pmt2∆ strain was incapable of growing at 42 °C, was sensitive to high salt concentrations, and showed increased sensitivity to cell wall-perturbing agents and antifungal drugs [39]. Thus, it has been proposed that Pmt2, along with Pmt1 and Pmt4 are responsible for most of the Pmt activity, and Pmt5 and Pmt6 have a regulatory activity, in particular of the targeted protein for O-linked mannosylation [37]. Similar to Saccharomyces cerevisiae, it has been proposed that Pmt1 and Pmt2 form a functional heterodimer to catalyze the transference of the monosaccharide to proteins [40].
Currently, there is limited information on the contribution of O-linked mannans to C. tropicalis biology and interaction with the host. The approaches used to study this cell component are the chemical removal by β-elimination or the analysis of the pmr1∆ null mutant, which is affected in both N-linked and O-linked mannan synthesis [15,17]. PMR1 product is a Golgi-resident P-type Ca2+/Mn2+-ATPase that controls Mn2+ homeostasis in this organelle and consequently regulates the Mn2+-dependent mannosyltransferases [20]. Here, we generated a C. tropicalis pmt2∆ null mutant and performed phenotypical characterization, in particular on the cell wall composition and the interaction with the host.

2. Materials and Methods

2.1. Strains and Culturing Conditions

The strains used in this study are listed in Table 1. Yeast maintenance and propagation were performed by growing at 28 °C in YPD medium [2% (w/v) bacteriological peptone, 1% (w/v) yeast extract, and 2% (w/v) dextrose] or SC medium [0.67% (w/v) yeast nitrogen base with ammonium sulfate with amino acids, and 2% (w/v) glucose]. When a solid medium was required, the broth was added with 2% (w/v) agar. Filamentation in the solid medium was stimulated by growing yeast cells on solid Spider medium at 30 °C [41], while in a liquid medium, it was stimulated in RPMI 1640 supplemented with 2.5% (v/v) fetal calf serum and incubating 3.5 h at 37 °C and shaking (150 rpm) [42]. For recycling of the SAT1 marker, cells were grown in YEP broth [2% (w/v) bacteriological peptone and 1% (w/v) yeast extract] at 28 °C. When required, cells were heat-killed by incubating at 56 °C for 60 min [43]. For analysis of the C. tropicalis–host interaction, yeasts were grown at 28 °C in YPD broth until reaching the logarithmic growth phase. When required, cells were heat-inactivated at 56 °C for 60 min. The viability lost was confirmed on YPD plates incubated at 28 °C for 48 h. For β-elimination, cells were suspended in 10 mL of NaOH 0.1 N and incubated at room temperature during 18 h, as reported [17]. The preparations were neutralized with HCl 0.1 N, and the cells pelleted by centrifuging, suspended in sterile phosphate-buffered saline (PBS), and kept at −20 °C until used.

2.2. Complementation of Candida albicans Mutants

To generate the complementation plasmid, the open reading frame (ORF) of CTRG_05668 (https://www.ncbi.nlm.nih.gov/nuccore/NW_003020061.1?from=229097&to=231394&report=fasta, accessed on 18 January 2019) was amplified by PCR with the primer pair 5’-AAGCTTATGTCTACTTCTGTTGAACCA-3’ and 5’-GCTAGC CTAGGTATATTTATCATCAGA-3’ (underlined sequences are added restriction sites for HindIII and NheI, respectively, to direct ligation to the plasmid). The 2298 bp amplicon was cloned into pCR®2.1-TOPO® (Thermo Fisher Scientific, Waltham, MA, USA), and then subcloned into the HindIII and NheI sites of pACT1-GFP [44], generating pACT1-CTRG_05668, which was digested with StuI and used to transform a C. albicans PMT2/pmt2∆ heterozygous mutant and a pmt6∆ null mutant [39,45]. Plasmid integration into the neutral RPS10 locus was confirmed by PCR, as reported [46].
The analysis of cell growth in the presence of cell wall-perturbing agents was performed as previously reported [17]. YPD-grown cells were washed three times with PBS, cell concentration adjusted at an OD600nm = 1.0, and diluted to achieve an OD600nm = 0.01 with fresh medium. Aliquots of 95 µL were added into 96-well plates, 5 µL of compounds were added to each well, plates were incubated 24 h at 28 °C and the absorbance at 600 nm was measured. Calcofluor white and Congo red were from Sigma-Aldrich (San Louis, MO, USA), and hygromycin B was from GoldBio (St Louis, MO, USA). Control wells containing 5 μL of PBS instead of the tested compounds were used to assess normal growth and to normalize data obtained with the cell wall-perturbing agents. Data are shown as a percentage of fungal growth without perturbing compounds.
Table 1. Strains used in this work.
Table 1. Strains used in this work.
StrainOrganismsOriginGenotypeReference
NGY152C. albicansDerived from CAI-4ura3Δ-iro1Δ::imm434/ura3Δ-iro1Δ::imm434; RPS1/rps1∆::CIp10[46]
P2-67C. albicansDerived from CAI-4ura3Δ-iro1Δ::imm434/ura3Δ-iro1Δ::imm434; PMT2/pmt2Δ::hisG[39]
CAP2-2341C. albicansDerived from CAI-4ura3Δ-iro1Δ::imm434/ura3Δ-iro1Δ::imm434; pmt6Δ::hisG/pmt6Δ::hisG[45]
HMY211C. albicansDerived from P2-67As P2-67 but RPS1/rps1∆::CIp10This work
HMY212C. albicansDerived from P2-67As P2-67 but RPS1/rps1∆:: pACT1-CTRG_05668This work
HMY213C. albicansDerived from CAP2-2341As CAP2-2341 but RPS1/rps1∆::CIp10 This work
HMY214C. albicansDerived from CAP2-2341As CAP2-2341 but RPS1/rps1∆:: pACT1-CTRG_05668This work
ATCC® MYA-3404C. tropicalisATCCWild typeATCC
HMY215C. tropicalisMYA-3404As ATCC MYA-3404, but pmt2Δ::sat1/PMT2This work
HMY216C. tropicalisHMY215As ATCC MYA-3404, but pmt2Δ/PMT2This work
HMY217C. tropicalisHMY216As ATCC MYA-3404, but pmt2Δ/pmt2Δ::sat1This work
HMY218C. tropicalisHMY217As ATCC MYA-3404, but pmt2Δ/pmt2ΔThis work
HMY219C. tropicalisHMY218As ATCC MYA-3404, but pmt2Δ/pmt2Δ::sat1-PMT2This work
HMY220C. tropicalisHMY219As ATCC MYA-3404, but pmt2Δ/pmt2Δ::PMT2vThis work

2.3. Disruption of Candida tropicalis PMT2

The SAT1 flipper method was used to disrupt the two PMT2 alleles [17]. To generate homologous recombination arms, a fragment of 1368 bp upstream the CTRG_05668 ORF was amplified by PCR, using the primer pair 5’-GGGCCCAGCTGCAAAATTAGTCTTT-3’ and 5’-CTCGAGTTGCTTGTTGTTTGTTGCTT-3’(underlined sequences correspond to added restriction sites for cloning); cloned in the pCR®2.1-TOPO® (Thermo Fisher Scientific); and then subcloned into ApaI and XhoI sites of pSFS2, generating pSFS2-upstream [47]. A similar strategy was used to generate the downstream recombination arm. For this, a 1201-bp amplicon was generated with the primer pair 5’-GCGGCCGCGACATTTCGCCTTTGATCCAAC-3’ and 5’-GAGCTCGTTGACTTGCCAATAAAAGAAGAAG-3’ (underlined sequences correspond to added restriction sites for cloning) and cloned into the NotI and SacI sites of pSFS2-upstream, generating the complete disruption cassette, which was ApaI- and SacI-digested before the fungal transformation. Strain ATCC® MYA-3404, considered as the wild-type (WT) parental strain here, was transformed with the disruption cassette and transformants were selected on YPD plates added with 200 µg mL−1 nourseothricin (Goldbio). To recycle the SAT1 marker, cells were grown for 2 days at 28 °C in YEP broth added with 2% (w/v) maltose and selected on YPD plates supplemented with 10 µg mL−1 nourseothricin. The strategy was repeated to disrupt the second allele. In all cases, PCR with primer pairs aligning inside and outside of the recombination regions was used to assess recombination events in the targeted locus.
To generate a reintegrant control strain, the CTRG_05668 ORF plus 1000 bp upstream and 500 bp downstream was amplified by PCR using the following primer pairs: 5’-GGGCCCGAGAGAGCAAACACATTAG-3’ and 5’-CTCGAGTTTAGGTATTATTCTTATATG-3’ (underlined sequences correspond to added restriction sites for cloning). The 3978 bp was cloned into the ApaI and XhoI sites of pSFS2 [17]. Then a 700 bp fragment downstream for the target ORF was amplified and cloned into the NotI and SacI sites of the same plasmid. This fragment was amplified with the primer pair 5’-GCGGCCGCATACCTAGATTTTATCTTCGCAT-3’ and 5’-GAGCTCATTAATCTAGTATATTTAAAATCATC-3’ (underlined sequences correspond to added restriction sites for cloning). The reintegration cassette was released by digesting with ApaI and SacI and used in fungal transformation. Similar to the null mutant strain generation, the SAT1 was recycled to have WT, null mutant, and reintegrant control strains sensitive to nourseothricin.

2.4. Gene Expression Analysis

Total RNA was extracted from yeasts and used for cDNA synthesis with an oligo(dT)20 primer. The cDNA was purified by chromatography and quantified in a NanoDrop 2000 (Thermo Fisher Scientific). Quantitative PCR reactions contained cDNA, SYBR Green PCR Master Mix, and a specific primer pair, and were performed in a thermocycler StepOne Plus (Life Technologies, Carlsbad, CA, USA). For data normalization, the ACT1 gene was amplified [48]. Data were analyzed in the StepOne software V 2.2 (Life Technologies) using the 2−∆∆Ct method [49]. The following primer pairs were used: for ACT1, 5’-GACCGAAGCTCCAATGAATC-3’ and 5’-AATTGGGACAACGTGGGTAA-3’; for PMT1, 5’-ACTTCTCATCACCACTGGCA-3’ and 5’-CGGCTGCCTAAGTAACCAAC-3’; for PMT2, 5’-GTGGTCCACGTGAAGTTTCC-3’ and 5’-TGGTGCTTGAACATCATGGG-3’; for PMT4, 5’-TGGTCCAGGTGATGCTTTCA-3’and 5’-TTTACCAGCACCTTCAACGG-3’; for PMT5, 5’-TCCGAAATTTTCATTCTGGCAA-3’ and 5’-CTGGTGAGTCAGTTGGTTGT-3’; for PMT6, 5’-AACTGCCGTGCTCTTAGGAT-3’ and 5’-GCAGTGACAAAGAGACCCAC-3’; for PKC1 (CTRG_02299), 5’-CCGGTGGTGATTTGATGTGG-3’ and 5’-CAAATGCCCACCAGTCAACA-3’; and for MKC1 (CTRG_01071), 5’-CGATGGCACGTCAACTAAGG-3’ and 5’-TTCCCGGTTTCAAGTCTCGA-3’.

2.5. Analysis of the Cell Wall

Yeasts were grown overnight at 28 °C in YPD, harvested by centrifuging, washed three times with PBS, and disrupted with glass beads in an MSK cell homogenizer (Braun, Melsungen, Germany). Homogenates were centrifuged, pelleted cell walls were saved, washed three times with PBS, and cleaned with hot SDS, β-mercaptoethanol, and NaCl, as reported [22]. Five mg of the cell wall were hydrolyzed with 2 M trifluoroacetic acid; the acid was removed by evaporation, and samples were analyzed by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD), as reported [50]. For this purpose, a CarboPac PA200 analytical column (3 × 250 mm) with a CarboPac PA200 guard column (3 × 50 mm) was used. Samples were eluted with an isocratic gradient of 3.2 mM NaOH with a flux rate of 0.15 mL min−1 for 20 min. For protein quantification, walls were boiled with 1 N NaOH for 30 min, and after neutralization with 1 N HCl, the protein content was quantified with the Pierce BCA Protein Assay (Thermo Fisher Scientific) [22].
To quantify N-linked mannans, cells were adjusted to 1 × 109 cells mL−1, suspended in 3 mM NaOAc and 25 U endoglycosidase H (New England Biolabs, Ipswich, MA, USA), and incubated at 37 °C for 24 h [51]. Reactions were neutralized, and centrifuged, and the soluble mannans were saved and kept at −20 °C until use. For O-linked mannans, a similar approach was used but cells were incubated overnight at room temperature with 0.1 N NaOH under gentle orbital shaking [38]. In both cases, mannans were hydrolyzed with trifluoroacetic acid and analyzed by HPAEC-PAD, as described [51]. The chitin exposure at the cell wall surface was analyzed by incubating yeasts with 0.5 mg mL−1 fluorescein isothiocyanate-conjugated wheat germ agglutinin (Sigma-Aldrich) for 60 min at room temperature [52]. For β-1,3-glucan analysis, yeasts were incubated with 5 μg mL−1 IgG Fc-dectin-1 chimera [53] for 40 min at room temperature followed by an incubation step with 1 μg mL−1 donkey anti-Fc IgG-FITC (Sigma-Aldrich). Fluorescence associated with cells was observed with a Zeiss Axioscope-40 microscope (Carl Zeiss AG, Jena, Germany) and an Axiocam MRc camera. A total of 300 cells were analyzed per sample, and the median fluorescence per cell was calculated, as described [54].
Cell wall porosity was analyzed by the relative ability of polycations to interact with the plasma membrane, as described [55], while phosphomannan content was estimated by the cellular ability to bind Alcian blue, as previously reported [56].

2.6. Analysis of Enzyme Activity

Secreted proteolytic activity was assessed by the degradation of bovine serum albumin (BSA) as reported. [57]. Overnight-grown yeast cells in YPD were washed three times with PBS, pelleted by centrifuging, with cell concentration adjusted to OD600nm = 0.4, and 100 µL was mixed with 300 µL 5.0% (w/v) BSA (Sigma-Aldrich) in 50 mM sodium citrate, pH 3.2, and incubated for 30 min at 37 °C. Reactions were centrifuged, the supernatant collected, 100 µL 2 M perchloric acid was added, and the mixture was incubated for 15 min at 4 °C. Protein content was estimated by reading the absorbance at 280 nm. Mock reactions with only cells supernatant were used to establish basal absorbance at 280 nm. The change in absorbance between the test and mock reactions per minute was defined as one enzyme unit.
For secreted lipolytic activity, aliquots of 100 µL cells adjusted to OD600nm = 0.4 were added with 100 µL of 40 mM 4-methylumbelliferyl palmitate (Sigma-Aldrich) in 50 mM MES-Tris buffer, pH 6.0, and incubated for 30 min at 37 °C. Then, 200 µL 50 mM glycine-NaOH buffer, pH 11.0, was added, reactions were centrifuged, and the supernatants were used to quantify the released 4-methylumbelliferone in an LS-5B luminescence spectrofluorometer (Perkin-Elmer, Waltham, MA, USA). Excitation and emission wavelengths were set at 350 nm and 440 nm, respectively, as reported [58]. One enzyme unit was defined as one nmole 4-methylumbelliferone generated per minute.
To determine intracellular enzyme activities, cells were pelleted by centrifuging and disrupted in an MSK cell homogenizer (Braun). Cell homogenates were treated as described above.

2.7. Sensitivity to Antifungal Drugs

Overnight cultures were used to inoculate fresh YPD broth and incubated at 28 °C until the exponential phase (typically 5 h). Cells were harvested by centrifuging, washed three times with PBS, and suspended in RPMI-1640 medium with MOPS and L-glutamine, without sodium bicarbonate (Sigma-Aldrich). The sensitivity to antifungal drugs was assessed following the M27-A3 protocol, while the interpretation of minimal inhibitory concentrations (MIC) was performed as suggested in the M27-S4 protocol [59]. The drugs tested were amphotericin B, fluconazole, and caspofungin (all from Sigma-Aldrich). Amphotericin B and caspofungin were tested in a range from 32 to 0.125 μg mL−1, whilst for fluconazole, the dilutions tested were from 1024 to 1 μg mL−1.

2.8. Analysis of Biofilm Formation

Biofilm stimulation and analysis were performed as reported [60,61]. Yeasts were suspended in PBS, cell concentration adjusted to 1 × 107 cells mL1, and 100 µL PBS was placed in flat-bottom Nunc polystyrene 96-microtiter plates (Thermo Fisher Scientific). Cell adhesion was allowed to occur for 4 h at 30 °C. Then, wells were washed three times with PBS, 100 µL RPMI-1640 medium supplemented with L-glutamine (Sigma-Aldrich) was added to each well, and plates were incubated for 24 h at 37 °C. Cell biomass within biofilms was assessed by staining with 0.02% (w/v) crystal violet and reading absorbance at 590 nm, as reported [60]. To analyze the biofilm extracellular matrix, the media were removed from mature biofilms, and 200 µL of 50 µg mL1 chitinase from Streptomyces griseus (Sigma-Aldrich) was added to each well and incubated at 25 °C for 2 h. Then, wells were sonicated for 5 min with a Q700 Sonicator (Thomas Scientific, Swedesboro, NJ, USA), and the supernatant was collected after centrifuging and kept at −20 °C until used [62]. These soluble fractions were concentrated in an Amicon Ultra centrifugal filter with Ultracel-3K (Sigma-Aldrich) and used to quantify glucose and glucosamine by HPAEC-PAD, as reported [51]. The pelleted cells from detached biofilms were serially diluted and grown on YPD plates at 28 °C for 24 h, for colony-forming unit quantification.

2.9. Adhesion Assays

Adhesion to components of the extracellular matrix was analyzed by ELISA [63]. Plates were prepared by adding 100 µL of 1.0 µg 100 µL−1 of extracellular matrix components in 0.05% (w/v) PBS–Tween 20 to wells of Nunc MaxiSorp™ flat-bottom 96-well microplates (Thermo Fisher Scientific). These were incubated for 3 h at room temperature, washed three times with 0.05% (w/v) PBS–Tween 20, and blocked with 1% (w/v) bovine serum albumin (BSA) in PBS overnight at 4 °C. Plates were washed three times with 0.05% (w/v) PBS–Tween 20 before assessing adhesion.
Aliquots of 100 µL containing 5 × 106 yeasts in PBS were added per well, and incubated for 1 h at 37 °C. Then, plates were washed three times with 0.05% (w/v) PBS–Tween 20, 100 µL of polyclonal anti-Candida antibody (Thermo-Fisher Scientific, cat number PA1-27158) diluted at 1:3000 was added, and the plates were incubated for 2 h at room temperature. Plates were washed with 0.05% (w/v) PBS–Tween 20, 100 µL of goat anti-rabbit IgG-peroxidase antibody (Sigma-Aldrich) was added at a working dilution of 1:5000, and the plates were further incubated for 2 h at room temperature. Peroxidase activity was revealed with 0.1 mg mL−1 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt and 0.006% (v/v) hydrogen peroxide. Plates were incubated for 20 min at room temperature, 2 N sulfuric acid was added, and the plates were read at 450 nm in a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific). The extracellular matrix components were human laminin, elastin, fibrinogen, recombinant fibronectin, recombinant thrombospondin-1, type I collagen, or bovine type II collagen (all from Sigma-Aldrich).

2.10. Ethics Statement

This study involved the use of human blood. Samples were withdrawn from healthy donors who previously signed an informed consent statement. This study was approved by the Ethics Committee of Universidad de Guanajuato (reference CIBIUG-P26-2020) and conducted following the Declaration of Helsinki.

2.11. Cytokine Stimulation by Human Peripheral Blood Mononuclear Cells

Human venous blood samples were collected in tubes containing EDTA, and used to separate PBMCs by differential centrifugation in Histopaque-1077 (Sigma-Aldrich), as reported [64]. The PBMC–Candida interactions were performed in U-bottom 96-well microplates, containing 200 µL RPMI 1640 Dutch modification (added with 2 mM glutamine, 0.1 mM pyruvate, and 0.05 mg mL−1 gentamycin; all reagents from Sigma-Aldrich), 1 × 105 yeast-like cells, and 5 × 105 PBMCs. Plates were incubated at 37 °C for 24 h with 5% (v/v) CO2 and centrifuged for 10 min at 1800× g at 4 °C. The supernatants were collected and kept at −20 °C until used for cytokine quantification by ELISA [17]. Human tumor necrosis factor-alpha (TNFα), interleukin 6 (IL-6), interleukin 1β (IL-1β), and interleukin 10 (IL-10) were quantified with Standard ABTS ELISA Development kits (Peprotech, Cranbury, NJ, USA). A calibration curve was included in each ELISA plate along with negative control wells, containing supernatant from PBMCs incubated only with culturing medium. In some experiments, human PBMCs were preincubated for 1 h at 37 °C with 200 μg mL−1 laminarin (Sigma-Aldrich) [17] before interacting with yeasts.

2.12. Phagocytosis Assays

Human PBMCs were differentiated into macrophages by incubating with recombinant human granulocyte–macrophage colony-stimulating factor (Sigma-Aldrich), as reported [54]. Yeasts were labeled with 1 mg mL−1 Acridine Orange (Sigma-Aldrich) at room temperature for 30 min, the excess dye was removed by washing with cold PBS, and cell concentration was adjusted to 3 × 107 cells mL−1 [17]. The phagocytosis assays were performed in 6-well plates, with an immune cell/fungus ratio of 1:6 in 800 µL of DMEM medium (Sigma-Aldrich). The plates were incubated at 37 °C for 2 h and 5% (v/v) CO2 and cells were detached with cold PBS and incubated with 1.25 mg mL−1 Trypan Blue [17]. Cells were analyzed in a FACSCanto II system (Becton Dickinson, Franklin Lakes, NJ, USA) using the FL1 and FL2 channels calibrated with non-stained monocyte-derived macrophages. Fifty thousand events were collected per sample. The use of two channels allowed to classification of cells in the early, intermediate, and late stages of phagocytosis, as reported [65]. The preincubation with laminarin was performed as described in Section 2.11.

2.13. Analysis of Virulence

The analysis was performed in Galleria mellonella larvae from an in-house colony [66]. Insects were fed ad libitum with a conventional diet based on corn bran and honey [67]. Only larvae measuring between 1.2 and 1.5 cm in length, with active behavior and no body melanization were included in this study. Cells were used at a concentration of 2 × 107 yeasts in 10 μL of PBS to inoculate larvae in the last left pro-leg, using a Hamilton syringe and a 26-gauge needle, as reported [66]. Infected larvae were kept at 37 °C under hydration ad libitum with chopped apple. Insects were inspected daily for 15 days, and those without response to external stimuli and with extensive body melanization were considered dead [66]. A total of 30 animals was used for each strain. One additional group injected only with PBS was also included as a control. To quantify colony-forming units, hemocyte concentration, phenoloxidase activity, melanin production, and cytotoxicity, the hemolymph was collected, anticoagulated, and assayed as reported [67]. Phenoloxidase activity was assayed using 20 mM 3,4-dihydroxyDL-phenylalanine (Sigma-Aldrich), while cytotoxicity was quantified with the Pierce LDH Cytotoxicity Assay (Thermo Fisher Scientific) [67].

2.14. Statistical Analysis

GraphPad Prism 6 software, version 6.07 was used for data analysis. Ex vivo and in vivo experiments were analyzed with the Mann–Whitney U and Kruskal–Wallis tests, whereas other results were analyzed with the parametric Student’s test. Statistical significance was set at p < 0.05. Larva mortality is shown in Kaplan–Meier survival curves and the log-rank test was used for data analysis.

3. Results

3.1. Disruption of Candida tropicalis PMT2

Thus far, the C. tropicalis PMT gene family has not been studied, and therefore, the putative functional orthologs in this species have been only predicted by bioinformatics analyses. Similar to C. albicans, there are five putative members of this gene family, and when comparative analyses were performed, it was predicted that C. tropicalis contains a putative ortholog for all of the C. albicans PMT family members (Figure 1). According to the guide tree constructed in Clustal Omega (https://www.ebi.ac.uk/jdispatcher/msa/clustalo, accessed on 30 April 2024), the sequence CTRG_05668 is the putative ortholog of C. albicans PMT2 (Figure 1), and the putative protein showed a similarity of 91.4%, 61.7%, 54.3%, 46.9%, and 45.6% to C. albicans Pmt2, Pmt6, Pmt1, Pmt4, and Pmt5, respectively. The open reading frame encodes for a 765 amino acids protein, with seven putative transmembrane domains and the N-terminal predicted to be in the cytoplasm (https://services.healthtech.dtu.dk/services/TMHMM-2.0/, accessed on 30 April 2024), similar to S. cerevisiae Pmt2 [68].
Since Pmt2 and Pmt6 belong to the same subfamily, and the putative protein encoded by CTRG_05668 showed high similarity to both C. albicans Pmt2 and Pmt6, we expressed this gene in the C. albicans PMT2/pmt2∆ [39] and a pmt6∆ null mutant [45] to assess functional complementation. Since both mutant strains are Ura--, the heterologous complementation was performed with the pACT1-GFP, where the GFP ORF was substituted with the C. tropicalis CTRG_05668 ORF and transcription was controlled with the strong and constitutive ACT1 promoter [44]. It was previously reported that the C. albicans PMT2/pmt2∆ heterozygous mutant showed increased sensitivity to the cell wall-perturbing agents calcofluor white, Congo red, and hygromycin B, along with poor filamentation in Spider medium and inability to grow at 42 °C [39]. After complementation with the CTRG_05668 ORF, the mutant strain restored the sensitivity to the three perturbing agents to levels similar to the WT control strain (Figure 2A) and underwent dimorphism in the solid Spider medium (Figure 2B). In addition, cells grew at 42 °C as the WT control strain. Contrary to the PMT2 heterozygous mutant, the pmt6∆ null mutant has a more discrete phenotype, with increased sensitivity only to hygromycin B and delayed filamentation on solid medium [45]. Both phenotypes were not restored upon transformation with pACT1-CTRG_05668 (Figure 2A,B). Therefore, our result suggests that CTRG_05668 is the functional ortholog C. albicans PMT2 and named hereafter PMT2.
A C. tropicalis pmt2∆ null mutant was generated following the SAT1 flipper methodology and contrary to the observations in C. albicans, both alleles were disrupted with no viability loss. To associate any phenotype to the PMT2 disruption, a reintegrant control strain was generated using the same recycling cassette. For both the null mutant and reintegrant control strain, the SAT1 marker was recycled to generate nourseothricin-sensitive cells, like the WT control strain. In all cases, cassette integration into the targeted locus was confirmed by PCR The pmt2∆ did not form cell aggregates and the colony morphology was similar to that observed in the WT and reintegrant control strains. Despite this apparent normal phenotype, the pmt2∆ null mutant showed increased doubling times when compared with the WT control strain (doubling times of 1.52 ± 0.14 h and 2.28 ± 0.22 h, for WT and pmt2∆ null mutant, respectively, p < 0.05), and this was recovered to WT levels in the reintegrant strain (1.46 ± 0.28 h, p > 0.05 when compared with the WT control strain). The null mutant failed to grow at 42 °C and underwent dimorphism in both liquid and solid medium (Figure 3).
We hypothesized that PMT2 disruption may affect the expression of other PMT family members, and thus, their expression was quantified in cells growing in YPD, SC medium, or under conditions to stimulate filament growth. In all these, none of the family members showed any significant differential expression when compared to the WT control cells or the reintegrant control strain (Table 2), suggesting the lack of complementation upon PMT2 disruption.

3.2. The Candida albicans pmt2∆ Null Mutant Showed Defects in Cell Wall Composition and Organization

Since O-linked mannans are found as part of the cell wall proteins, we hypothesized that PMT2 disruption may affect wall composition. Cell walls were isolated from yeasts, acid hydrolyzed to break down polysaccharides and oligosaccharides, and the released monosaccharides were analyzed by HPAEC-PAD [17,22]. The null mutant strain showed mannan levels similar to the WT and control cells (p = 0.098), but a significant increment in glucan content (Figure 4A). The chitin content was not affected by PMT2 disruption (Figure 4A). In addition, the cell wall protein content was reduced in the null mutant, a phenotype that was restored to WT levels in the reintegrant control strain (Figure 4B). When N- and O-linked mannans were trimmed off from walls and quantified, we observed similar N-linked mannan levels for WT, mutant, and reintegrant control strain, but for O-linked mannans, these were reduced by about 75% in the pmt2∆ null mutant strain (Figure 4C). Once again, this wall component was found at WT levels in the reintegrant control strain (Figure 4C). Since the β-glucan levels were increased in the pmt2∆ null mutant strain, we also measured the relative exposure of this structural polysaccharide at the cell wall surface. We used a lectin-based approach where bulky lectins are only accessible to their targets if they are exposed to the cell surface [52,69]. Chitin was partially exposed at the cell surface of the WT strain since lectin labeling readily occurred in artificially permeabilized walls by heat (heat-killed cells, HK) than in live cells (Figure 4D). A similar profile was observed with both the mutant and reintegrant strain, suggesting no changes in chitin exposure at the cell surface (Figure 4D). The β-1,3-glucan labeling followed the same trend in the WT strain, with poor labeling in live cells and significant levels of fluorescence associated with HK cells (Figure 4D). However, the pmt2∆ null mutant showed higher β-1,3-glucan labeling in both live and HK cells, suggesting increased exposure on the cell surface and higher cell wall content, respectively (Figure 4D). This labeling was restored to WT levels in the reintegrant control strain (Figure 4D). The cell wall porosity and the phosphomannan content were not affected in the pmt2∆ null mutant (relative porosity to DEAE-dextran: 52.4 ± 6.4 and 50.6 ± 5.5 for WT and null mutant, respectively; µg of Alcian blue bound per OD600nm = 1.0:90.6 ± 8.9 and 88.4 ± 6.6 for WT and pmt2∆ null mutant, respectively).
Changes in cell wall components are associated with the activation of the cell wall integrity pathway [70,71,72,73,74]. This adaptation mechanism involves the activation of Pkc1 and Mkc1, leading to compensatory increments of structural polysaccharides [17,71]. Thus, the increment of β-1,3-glucan in the C. tropicalis pmt2∆ null mutant may be explained by the activation of the cell wall integrity pathway. The expression of both genes was upregulated in the pmt2∆ null mutant when compared to the WT strain (Table 3). As expected, the gene expression was restored to WT levels in the reintegrant control strain (Table 3). These data suggest activation of the cell wall integrity pathway upon PMT2 disruption.
The reduction of cell wall protein content in the pmt2∆ null mutant may reflect a defect in protein secretory pathways that deliver polypeptides to the cell wall. Thus, we measured two well-known C. tropicalis-secreted enzyme activities: acid proteinase, and lipase [75,76,77]. Both secreted protease and lipase activities were significantly reduced in the pmt2∆ null mutant when compared to the WT cells, and this phenotype was restored in the reintegrant control strain (Table 4). In agreement with a defect in protein secretion, the null mutant accumulated both activities intracellularly Thus, these results suggest that PMT2 disruption affects secretory pathways in C. tropicalis.

3.3. The Candida tropicalis pmt2∆ Null Mutant Showed Defects in the Sensitivity to Cell Wall-Perturbing Agents, Biofilm Formation, and Adhesion

Since the C. albicans PMT2/pmt2∆ mutant showed defects in the sensitivity to cell wall-perturbing agents [39], we also assessed whether this phenotype was present in the C. tropicalis pmt2∆ null mutant. The null mutant cells showed increased sensitivity to Congo red and hygromycin B (Figure 5), and this phenotype was restored in the reintegrant control strains (Figure 5). In line with our observations of chitin levels in the mutant cells, PMT2 disruption did not affect sensitivity to calcofluor white (Figure 5).
The sensitivity to some antifungal drugs was also tested but the pmt2∆ null mutant did not show significant differences when compared to the WT cells (MIC of 0.5 µg mL−1 for amphotericin B for both strains; MIC of 1.0 µg mL−1 for caspofungin for both strains; and MIC of 4.0 µg mL−1 fluconazole for both strains). Regarding biofilm formation, the pmt2∆ null mutant showed a defect in establishing a biofilm, with a reduction in the cell content and extracellular matrix components such as glucose, glucosamine, and protein, signature elements of C. tropicalis biofilms [62].
Next, the adhesive properties of the pmt2∆ null mutant were investigated using different components of the extracellular matrix. We used an ELISA-based approach that has been previously useful to analyze the adhesion of other fungal species with extracellular matrix components [63]. The WT control strain showed high adhesive levels to laminin, and fibronectin, intermediate levels to elastin and type I and type II collagen, and low adhesion to fibrinogen and thrombospondin-1 (Figure 6). The WT and the pmt2∆ null mutant showed similar adhesion levels to laminin, elastin, fibrinogen, and thrombospondin-1, but low adhesion to fibronectin and type I and type II collagen (Figure 6). The reintegrant control strain showed an adhesion profile similar to that observed in the WT strain. Collectively, these data indicate that PMT2 disruption affects C. tropicalis sensitivity to cell wall-perturbing agents, biofilm formation, and adhesion to extracellular matrix components.

3.4. The PMT2 Disruption Affected the Candida tropicalis Interaction with Human Peripheral Blood Mononuclear Cells and Monocyte-Derived Macrophages

To assess the impact of PMT2 disruption on the ability of C. tropicalis to interact with the host, we first assessed ex vivo the ability to stimulate cytokine production by human PBMCs. Our group previously analyzed the cytokine profile of the WT strain and β-eliminated yeasts and found that only IL-10 production is affected, increasing the levels upon chemical elimination of O-linked mannan [17]. Here, the proinflammatory cytokines TNFα, IL-1β, and IL-6 were stimulated at the same level in the WT, pmt2∆, and reintegrant control strain, indicating a dispensable role of O-linked mannans for the stimulation of these cytokines (Figure 7A). However, IL-10 production was positively affected in the pmt2∆ null mutant strain (Figure 7A). When cells were β-eliminated, an increment only in IL-10 levels was observed in human cells stimulated with the WT and reintegrant control strains, to a similar extent as the levels stimulated by the null mutant strain (Figure 7A). The IL-10 levels stimulated by the mutant were similar to the untreated and β-eliminated cells (Figure 7A). Since IL-10 was the only affected cytokine by PMT2 disruption, we further analyzed the stimulation of this cytokine, using heat-killed (HK) cells. This treatment artifactually exposed inner wall components at the cell surface, allowing for their interaction with immune receptors [43,78]. As previously reported, HK cells stimulated higher IL-10 levels than live cells [17] in the case of the WT and reintegrant control strain (Figure 7B). A similar trend was observed for β-eliminated cells and the pmt2∆ null mutant, indicating inner wall components play a dominant role in IL-10 stimulation (Figure 7B). Previously, it was demonstrated that dectin-1–β-1,3-glucan interaction is dominant in cytokine stimulation by C. tropicalis [17]. Thus, we hypothesize the increased ability of the pmt2∆ null mutant to stimulate IL-10 may be related to this pathway. Laminarin is a blocking agent for dectin-1 and precludes its interaction with its ligand [79]. Human PBMCs preincubated with laminarin were unable to stimulate high levels of IL-10 in the three studied strains, regardless they were live, HK, or β-eliminated cells, suggesting dectin-1 is involved in the increased ability of the pmt2∆ null mutant to stimulate this cytokine (Figure 7B).
When the mutant strain was used in phagocytosis experiments, along with human monocyte-derived macrophages, we observed increased cell numbers in the early, intermediate, and late stages of phagocytosis compared to the WT strain (Figure 8A). The reintegrant control strain showed uptake levels comparable to those observed with the WT strain (Figure 8B). The results related to cell wall composition, and IL-10 stimulation in human PBMCs, along with the observation that dectin-1 is the main player in C. tropicalis uptake by human monocyte-derived macrophages [17], led us to hypothesize that the increased phagocytosis in the pmt2∆ null mutant could be due to the interaction of dectin-1 with β-1,3-glucan. When the human cells were preincubated with laminarin, fungal uptake was significantly reduced for the three fungal strains, supporting our hypothesis. Overall, the results indicate the PMT2 disruption affected the interaction of C. tropicalis with human PBMCs and monocyte-derived macrophages.

3.5. Candida tropicalis PMT2 Disruption Lead to Virulence Attenuation in Galleria mellonella

Virulence was analyzed in G. mellonella larvae, in groups containing 30 individuals. After injection of a lethal concentration of C. tropicalis into the hemocele [67], the animal group inoculated with the WT strain showed a median survival of 2.0 ± 0.5 days, whereas the animal group inoculated with the pmt2∆ null mutant had a median survival of more than 15 days, and only 33 ± 3.0% and larvae die during the observation period (Figure 9). The reintegrant control strain showed a killing curve similar to that generated with the WT strain, with a median survival of 2.0 ± 1.0 days (Figure 9). The control group where larvae were inoculated only with PBS did not show mortality during the 15 days of observation (Figure 9). It is noteworthy that despite these differences in the killing curves, the fungal burden in the larva hemolymph was similar for the three strains (Table 5).
Previous work has proposed early virulence predictors when C. tropicalis interacts with G. mellonella larvae [67]. There are cellular and humoral immunological parameters, along with cytotoxicity that change depending on the virulence of the isolate [67]. Hemocyte content was reduced in the hemolymph of animals inoculated with WT or the reintegrant control strain but not with the pmt2∆ null mutant, which was closer to the levels observed in the group inoculated with PBS (Table 5). Similarly, melanin and phenoloxidase activity in hemolymph tended to increase in larvae infected with the WT or reintegrant strain, while both parameters were significantly reduced in larvae infected with the pmt2∆ null mutant (Table 5). Cytotoxicity, measured as the cell-free lactate dehydrogenase levels found in hemolymph [80], was high in the animal group inoculated with the WT or reintegrant control strain but lower in that interacting with the null mutant. In all cases, this animal group was closer to the values generated with the PBS-injected group than to that inoculated with the WT strain (Table 5). Collectively, these data indicate that PMT2 is required for C. tropicalis virulence in G. mellonella larvae.

4. Discussion

As mentioned, C. tropicalis is a relevant pathogen for humans, and despite the high frequency of isolation from candidiasis and candidemia cases, little is known about basic biological aspects [81]. This may be explained by the fact that C. albicans is a model organism to study yeast-caused mycosis and it has frequently been assumed that observations in this organism may be extrapolated to other members of the same genus. However, there is growing evidence that these organisms have significant genomic and phenotypical differences [81,82,83,84,85]. Thus, it is not surprising that in this case, the relevance of PMT2 for cell viability in C. tropicalis is different from that observed in C. albicans. In S. cerevisiae, PMT2 disruption is not lethal [86], but in Cryptococcus neoformans, it is an essential gene [87], suggesting that the essentiality of this gene might be a species-specific trait. We currently do not have an explanation based on experimental data for the discrepant role of PMT2 in these two Candida species. It is known that pmt2 has interactions with pmt1 and pmt5 in S. cerevisiae [88]. These interactions between different family members determine the targeted protein to be glycosylated, including proteins for cell division, growth, mating, and cell wall fitness [37]. It is assumed that similar interactions would occur in C. albicans [89], even though no experimental proof has been reported. Thus, it is possible to speculate that these protein–protein interactions may occur differently in these fungal species, and consequently, the target proteins for Pmt2 or the dimers including this protein are different. This implies that in C. tropicalis, the Pmt2 targets are proteins involved in non-essential processes. This is in line with the observation that cells did not aggregate and showed a canonical morphology. One possible explanation for the defect in growth rate and filamentation is associated with the observed defects in the cell wall. These phenotypes have been reported in C. albicans and C. tropicalis null mutants with defects in the cell wall composition or organization [17,19,20,21,22,39,46,52].
We have previously reported that O-linked mannans are a minor component of the C. tropicalis cell wall [17], and our results here confirm this observation. Even though there was a significant reduction in O-linked mannan content, the total cell wall mannan levels were not significantly affected. The transcriptional levels of C. albicans PMT1, PMT2, and PMT4 are similar under normal growth conditions [90], and this is different in C. tropicalis, where PMT2 and PMT4 are expressed more than PMT1. This may explain the drastic reduction in O-linked mannans in the null mutant and also suggest that pmt2 may work in collaboration with Pmt4. Previously, the C. albicans heterozygous PMT2/pmt2∆ null mutant did not show changes in the cell wall composition [39], contrasting with the increment in β-1,3-glucan content, its exposure at the cell surface, and the activation of the cell wall integrity pathway in the C. tropicalis mutant. Once again, this difference may be explained by different target proteins for Pmt2 in the two species. In line with this hypothesis, in S. cerevisiae, there are target proteins for Pmt2 that are involved in cell wall elaboration and integrity [37].
The contribution of O-linked mannosylation for proper biofilm formation was analyzed in C. albicans, and Pmt1, Pmt2, Pmt4, and Pmt6 are required for the establishment and maturation of biofilms [91]. Here, we found a similar observation for C. tropicalis PMT2, indicating a conserved contribution of this protein for biofilm formation in both species. It was previously demonstrated that N-linked mannosylation is relevant for biofilm formation in C. tropicalis, as disruption of this metabolic pathway negatively affected protein secretion and biofilm maturation [36]. Because both biofilm formation and protein secretion were negatively affected by PMT2 disruption, it is feasible to propose a similar role for O-linked mannosylation in biofilm formation.
C. tropicalis can bind different types of primary human cells, cell lines, and to the surface of indwelling materials [84]. Thus far, little is known about the ability of this organism to adhere to extracellular matrix components. It can bind fibronectin, vitronectin, and laminin, with the binding to fibronectin being sensitive to cell pretreatment with mannosidase [92]. This mannosidase treatment is expected to trim mannans from cell wall glycoproteins and, consequently, disrupt its structure and function [92]. The reduction in binding to fibronectin by the pmt2∆ null mutant is in line with this observation and indicates that glycoproteins containing O-linked mannans are responsible for the binding of this extracellular matrix component. No evidence in the literature was found regarding the binding to collagens, making this report the first to document this observation. In C. albicans, the heterozygous PMT2/pmt2∆ null mutant did not show adhesion defects to an oral epithelial cell line, but the double mutant mnt1-mnt2∆ null mutant, which has a defect in the elongation of the O-linked mannans [23], showed lower adhesion to buccal epithelial cells, indicating that O-linked mannans in both organisms have similar relevance for adhesion.
The role of O-linked mannans during the interaction of C. albicans or C. tropicalis with human PBMCs is minor during cytokine stimulation [17,26,27]. The loss of elongated O-linked mannans marginally affects the stimulation of proinflammatory cytokines, and thus far, only IL-10 levels are affected in C. tropicalis with truncated O-linked mannans on the cell surface [17,27]. Here, our results showed a similar trend for the pmt2∆ null mutant, confirming these observations and offering an explanation for the incremented levels of Il-10, namely, increased engagement of dectin-1 with β-1,3-glucan exposed at the cell surface. Similar to this observation, it was reported that the C. albicans heterozygous PMT2/pmt2∆ null mutant stimulated increased IL-10 levels in murine macrophages [93]. Our phagocytosis results are in line with observations in C. albicans. The mnt1-mnt2∆ null mutant showed increased phagocytosis by murine macrophages, similar to the C. tropicalis pmt2∆ null mutant. However, the phagocytosis event is different in both species, as β-1,3-glucan and N-linked mannans are the main players of the uptake event in C. albicans, while phosphomannan and β-1,3-glucan are the main cell wall components involved in C. tropicalis phagocytosis [17,24,94].
The PMT family is required for virulence in C. albicans, and the heterozygous PMT2/pmt2∆ null mutant showed virulence attenuation in a murine model of systemic candidiasis [95], and defects in invasion and damage to an oral epithelial cell line [96]. Here, the C. tropicalis pmt2∆ null mutant also showed an avirulent phenotype, indicating this role is conserved in both species. Despite this observation, it is unlikely this protein is a virulence factor, because it has no direct function in host damage. Instead, it may be considered a virulence determinant. Similar CFUs recovered from larvae suggest that the growth defect observed in vitro is not occurring in the in vivo setting. This implies that the relevance of this gene for cell growth and adaptation to different growing conditions varies depending on the environment. This is supported by our results about the PMT2 expression levels under different growing conditions. Similarly, it was reported that the behavior of the C. albicans heterozygous PMT2/pmt2∆ null mutant, in terms of filamentation, changes in vitro and in vivo conditions [39,93].
In conclusion, we report here that a C. tropicalis pmt2∆ null mutant was generated, and its phenotypical characterization indicated this gene is required for proper cell wall organization, biofilm formation, adhesion to fibronectin, and type I and type II collagen. In addition, the PMT2 loss led to defects in the interaction with human PBMCs, monocyte-derived macrophages, and virulence attenuation in G. mellonella.

Author Contributions

Conceptualization, H.M.M.-M.; methodology, M.J.H.-C., I.M.-D., D.M.C.-G., L.A.L.-R. and H.M.M.-M.; investigation, M.J.H.-C., I.M.-D., D.M.C.-G. and L.A.L.-R.; resources, H.M.M.-M.; data curation, M.J.H.-C., H.M.M.-M. and I.M.-D.; writing—original draft preparation, H.M.M.-M.; supervision, H.M.M.-M. and I.M.-D.; project administration, H.M.M.-M.; funding acquisition, H.M.M.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Consejo Nacional de Humanidades, Ciencias y Tecnologías [Ciencia de Frontera 2019-6380 and CBF2023-2024-655] and Red Temática Glicociencia en Salud [CONACYT-México]. The funding sources that supported this work did not have any involvement in the design, acquisition, and analysis of the data or the writing of the manuscript.

Institutional Review Board Statement

This study involved the use of human blood. Samples were withdrawn from healthy donors who previously signed an informed consent statement. This study was approved by the Ethics Committee of Universidad de Guanajuato (reference CIBIUG-P26-2020) and conducted following the Declaration of Helsinki.

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Kreulen, I.A.M.; de Jonge, W.J.; van den Wijngaard, R.M.; van Thiel, I.A.M. Candida spp. in human intestinal health and disease: More than a gut feeling. Mycopathologia 2023, 188, 845–862. [Google Scholar] [CrossRef] [PubMed]
  2. Falagas, M.E.; Apostolou, K.E.; Pappas, V.D. Attributable mortality of candidemia: A systematic review of matched cohort and case-control studies. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25, 419–425. [Google Scholar] [CrossRef]
  3. Lass-Flörl, C.; Kanj, S.S.; Govender, N.P.; Thompson, G.R., 3rd; Ostrosky-Zeichner, L.; Govrins, M.A. Invasive candidiasis. Nat. Rev. Dis. Primers 2024, 10, 20. [Google Scholar] [CrossRef] [PubMed]
  4. Abdel-Hamid, R.M.; El-Mahallawy, H.A.; Abdelfattah, N.E.; Wassef, M.A. The impact of increasing non-albicans Candida trends on diagnostics in immunocompromised patients. Braz. J. Microbiol. 2023, 54, 2879–2892. [Google Scholar] [CrossRef] [PubMed]
  5. Otto, C.; Babady, N.E. Epidemiology and outcomes of non-albicans Candida bloodstream infections in transplant recipients and cancer patients. Mycopathologia 2023, 188, 863–871. [Google Scholar] [CrossRef] [PubMed]
  6. Kothavade, R.J.; Kura, M.M.; Valand, A.G.; Panthaki, M.H. Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fluconazole. J. Med. Microbiol. 2010, 59, 873–880. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, H.; Xu, Y.C.; Hsueh, P.R. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future Microbiol. 2016, 11, 1461–1477. [Google Scholar] [CrossRef] [PubMed]
  8. Won, E.J.; Sung, H.; Kim, M.N. Changing epidemiology of clinical isolates of Candida species during the Coronavirus Disease 2019 Pandemic: Data analysis from a Korean tertiary care hospital for 6 years (2017–2022). J. Fungi 2024, 10, 193. [Google Scholar] [CrossRef]
  9. Gow, N.A.; Hube, B. Importance of the Candida albicans cell wall during commensalism and infection. Curr. Opin. Microbiol. 2012, 15, 406–412. [Google Scholar] [CrossRef]
  10. Gómez-Gaviria, M.; García-Carnero, L.C.; Tamez-Castrellón, A.K.; Mora-Montes, H.M. The cell wall of medically relevant yeasts and molds. In Encyclopedia of Mycology; Zaragoza, Ó., Casadevall, A., Eds.; Elsevier: Oxford, UK, 2021; pp. 12–22. [Google Scholar]
  11. Hopke, A.; Brown, A.J.P.; Hall, R.A.; Wheeler, R.T. Dynamic fungal cell wall architecture in stress adaptation and immune evasion. Trends Microbiol. 2018, 26, 284–295. [Google Scholar] [CrossRef]
  12. Latgé, J.P. Tasting the fungal cell wall. Cell Microbiol. 2010, 12, 863–872. [Google Scholar] [CrossRef]
  13. Bizerra, F.C.; Melo, A.S.; Katchburian, E.; Freymüller, E.; Straus, A.H.; Takahashi, H.K.; Colombo, A.L. Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species. Antimicrob. Agents Chemother. 2011, 55, 302–310. [Google Scholar] [CrossRef] [PubMed]
  14. Mesa-Arango, A.C.; Forastiero, A.; Bernal-Martínez, L.; Cuenca-Estrella, M.; Mellado, E.; Zaragoza, O. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med. Mycol. 2013, 51, 461–472. [Google Scholar] [CrossRef] [PubMed]
  15. Navarro-Arias, M.J.; Hernández-Chávez, M.J.; García-Carnero, L.C.; Amezcua-Hernández, D.G.; Lozoya-Pérez, N.E.; Estrada-Mata, E.; Martínez-Duncker, I.; Franco, B.; Mora-Montes, H.M. Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells. Infect. Drug Resist. 2019, 12, 783–794. [Google Scholar] [CrossRef] [PubMed]
  16. Kobayashi, H.; Matsuda, K.; Ikeda, T.; Suzuki, M.; Takahashi, S.; Suzuki, A.; Shibata, N.; Suzuki, S. Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains. Infect. Immun. 1994, 62, 615–622. [Google Scholar] [CrossRef] [PubMed]
  17. Hernández-Chávez, M.J.; Clavijo-Giraldo, D.M.; Novák, Á.; Lozoya-Pérez, N.E.; Martínez-Álvarez, J.A.; Salinas-Marín, R.; Hernández, N.V.; Martínez-Duncker, I.; Gácser, A.; Mora-Montes, H.M. Role of protein mannosylation in the Candida tropicalis-host interaction. Front. Microbiol. 2019, 10, 2743. [Google Scholar] [CrossRef] [PubMed]
  18. Bates, S.; Hall, R.A.; Cheetham, J.; Netea, M.G.; MacCallum, D.M.; Brown, A.J.; Odds, F.C.; Gow, N.A. Role of the Candida albicans MNN1 gene family in cell wall structure and virulence. BMC Res. Notes 2013, 6, 294. [Google Scholar] [CrossRef] [PubMed]
  19. Bates, S.; Hughes, H.B.; Munro, C.A.; Thomas, W.P.; MacCallum, D.M.; Bertram, G.; Atrih, A.; Ferguson, M.A.; Brown, A.J.; Odds, F.C.; et al. Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. J. Biol. Chem. 2006, 281, 90–98. [Google Scholar] [CrossRef]
  20. Bates, S.; MacCallum, D.M.; Bertram, G.; Munro, C.A.; Hughes, H.B.; Buurman, E.T.; Brown, A.J.; Odds, F.C.; Gow, N.A. Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. J. Biol. Chem. 2005, 280, 23408–23415. [Google Scholar] [CrossRef]
  21. Mora-Montes, H.M.; Bates, S.; Netea, M.G.; Castillo, L.; Brand, A.; Buurman, E.T.; Diaz-Jimenez, D.F.; Jan Kullberg, B.; Brown, A.J.; Odds, F.C.; et al. A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. J. Biol. Chem. 2010, 285, 12087–12095. [Google Scholar] [CrossRef]
  22. Mora-Montes, H.M.; Bates, S.; Netea, M.G.; Diaz-Jimenez, D.F.; Lopez-Romero, E.; Zinker, S.; Ponce-Noyola, P.; Kullberg, B.J.; Brown, A.J.; Odds, F.C.; et al. Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction. Eukaryot. Cell 2007, 6, 2184–2193. [Google Scholar] [CrossRef] [PubMed]
  23. Munro, C.A.; Bates, S.; Buurman, E.T.; Hughes, H.B.; Maccallum, D.M.; Bertram, G.; Atrih, A.; Ferguson, M.A.; Bain, J.M.; Brand, A.; et al. Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. J. Biol. Chem. 2005, 280, 1051–1060. [Google Scholar] [CrossRef] [PubMed]
  24. McKenzie, C.G.J.; Koser, U.; Lewis, L.E.; Bain, J.M.; Mora-Montes, H.M.; Barker, R.N.; Gow, N.A.R.; Erwig, L.P. Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect. Immun. 2010, 78, 1650–1658. [Google Scholar] [CrossRef] [PubMed]
  25. Estrada-Mata, E.; Navarro-Arias, M.J.; Perez-Garcia, L.A.; Mellado-Mojica, E.; Lopez, M.G.; Csonka, K.; Gacser, A.; Mora-Montes, H.M. Members of the Candida parapsilosis complex and Candida albicans are differentially recognized by human peripheral blood mononuclear cells. Front. Microbiol. 2015, 6, 1527. [Google Scholar] [CrossRef] [PubMed]
  26. Netea, M.G.; Brown, G.D.; Kullberg, B.J.; Gow, N.A. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008, 6, 67–78. [Google Scholar] [CrossRef] [PubMed]
  27. Netea, M.G.; Gow, N.A.; Munro, C.A.; Bates, S.; Collins, C.; Ferwerda, G.; Hobson, R.P.; Bertram, G.; Hughes, H.B.; Jansen, T.; et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Investig. 2006, 116, 1642–1650. [Google Scholar] [CrossRef] [PubMed]
  28. Netea, M.G.; Joosten, L.A.; van der Meer, J.W.; Kullberg, B.J.; van de Veerdonk, F.L. Immune defence against Candida fungal infections. Nat. Rev. Immunol. 2015, 15, 630–642. [Google Scholar] [CrossRef] [PubMed]
  29. Yadav, B.; Mora-Montes, H.M.; Wagener, J.; Cunningham, I.; West, L.; Haynes, K.; Brown, A.J.P.; Gow, N.A.R. Differences in fungal immune recognition by monocytes and macrophages: N-mannan can be a shield or activator of immune recognition. Cell Surf. 2020, 6, 100042. [Google Scholar] [CrossRef] [PubMed]
  30. Sheth, C.C.; Hall, R.; Lewis, L.; Brown, A.J.; Odds, F.C.; Erwig, L.P.; Gow, N.A. Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling. Med. Mycol. 2011, 49, 513–524. [Google Scholar] [CrossRef]
  31. Gómez-Gaviria, M.; Vargas-Macías, A.P.; García-Carnero, L.C.; Martínez-Duncker, I.; Mora-Montes, H.M. Role of protein glycosylation in interactions of medically relevant fungi with the host. J. Fungi 2021, 7, 875. [Google Scholar] [CrossRef]
  32. Rosati, D.; Pradhan, A.; van Heck, J.I.P.; Helder, L.; Jaeger, M.; Gow, N.A.R.; Joosten, L.A.B.; Williams, D.L.; Brown, A.J.P.; Bruno, M.; et al. C. albicans N-linked mannans potentiate the induction of trained immunity via Dectin-2. J. Infect. Dis. 2024. [Google Scholar] [CrossRef] [PubMed]
  33. Ocaña-Ortega, A.; Pérez-Flores, G.; Torres-Tirado, D.; Pérez-García, L.A. O-Linked glycans of Candida albicans interact with specific GPCRs in the coronary endothelium and inhibit the cardiac response to agonists. J. Fungi 2023, 9, 141. [Google Scholar] [CrossRef] [PubMed]
  34. Thompson, A.; da Fonseca, D.M.; Walker, L.; Griffiths, J.S.; Taylor, P.R.; Gow, N.A.R.; Orr, S.J. Dependence on Mincle and Dectin-2 varies with multiple Candida species during systemic infection. Front. Microbiol. 2021, 12, 633229. [Google Scholar] [CrossRef] [PubMed]
  35. Neumann, A.K.; Jacobson, K. A novel pseudopodial component of the dendritic cell anti-fungal response: The fungipod. PLoS Pathog. 2010, 6, e1000760. [Google Scholar] [CrossRef] [PubMed]
  36. Clavijo-Giraldo, D.M.; Pérez-García, L.A.; Hernández-Chávez, M.J.; Martínez-Duncker, I.; Mora-Montes, H.M. Contribution of N-Linked Mannosylation Pathway to Candida parapsilosis and Candida tropicalis Biofilm Formation. Infect. Drug Resist. 2023, 16, 6843–6857. [Google Scholar] [CrossRef] [PubMed]
  37. Lengeler, K.B.; Tielker, D.; Ernst, J.F. Protein-O-mannosyltransferases in virulence and development. Cell Mol. Life Sci. 2008, 65, 528–544. [Google Scholar] [CrossRef] [PubMed]
  38. Diaz-Jimenez, D.F.; Mora-Montes, H.M.; Hernandez-Cervantes, A.; Luna-Arias, J.P.; Gow, N.A.; Flores-Carreon, A. Biochemical characterization of recombinant Candida albicans mannosyltransferases Mnt1, Mnt2 and Mnt5 reveals new functions in O- and N-mannan biosynthesis. Biochem. Biophys. Res. Commun. 2012, 419, 77–82. [Google Scholar] [CrossRef] [PubMed]
  39. Prill, S.K.; Klinkert, B.; Timpel, C.; Gale, C.A.; Schröppel, K.; Ernst, J.F. PMT family of Candida albicans: Five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance. Mol. Microbiol. 2005, 55, 546–560. [Google Scholar] [CrossRef] [PubMed]
  40. Gentzsch, M.; Immervoll, T.; Tanner, W. Protein O-glycosylation in Saccharomyces cerevisiae: The protein O-mannosyltransferases Pmt1p and Pmt2p function as heterodimer. FEBS Lett. 1995, 377, 128–130. [Google Scholar] [CrossRef]
  41. Liu, H.; Kohler, J.; Fink, G. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 1994, 266, 1723–1726. [Google Scholar] [CrossRef]
  42. Mukaremera, L.; Lee, K.K.; Mora-Montes, H.M.; Gow, N.A.R. Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition. Front. Immunol. 2017, 8, 629. [Google Scholar] [CrossRef] [PubMed]
  43. Gow, N.A.R.; Netea, M.G.; Munro, C.A.; Ferwerda, G.; Bates, S.; Mora-Montes, H.M.; Walker, L.; Jansen, T.; Jacobs, L.; Tsoni, V.; et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J. Infect. Dis. 2007, 196, 1565–1571. [Google Scholar] [CrossRef] [PubMed]
  44. Barelle, C.J.; Manson, C.L.; MacCallum, D.M.; Odds, F.C.; Gow, N.A.; Brown, A.J. GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast 2004, 21, 333–340. [Google Scholar] [CrossRef] [PubMed]
  45. Timpel, C.; Zink, S.; Strahl-Bolsinger, S.; Schröppel, K.; Ernst, J. Morphogenesis, adhesive properties, and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen Candida albicans. J. Bacteriol. 2000, 182, 3063–3071. [Google Scholar] [CrossRef] [PubMed]
  46. Brand, A.; MacCallum, D.M.; Brown, A.J.; Gow, N.A.; Odds, F.C. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot. Cell 2004, 3, 900–909. [Google Scholar] [CrossRef] [PubMed]
  47. Reuß, O.; Vik, Å.; Kolter, R.; Morschhäuser, J. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 2004, 341, 119–127. [Google Scholar] [CrossRef]
  48. Contreras-Martínez, O.I.; Angulo-Ortíz, A.; Santafé-Patiño, G.; Aviña-Padilla, K.; Velasco-Pareja, M.C.; Yasnot, M.F. Transcriptional reprogramming of Candida tropicalis in response to isoespintanol treatment. J. Fungi 2023, 9, 1199. [Google Scholar] [CrossRef] [PubMed]
  49. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  50. Plaine, A.; Walker, L.; Da Costa, G.; Mora-Montes, H.M.; McKinnon, A.; Gow, N.A.; Gaillardin, C.; Munro, C.A.; Richard, M.L. Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity. Fungal Genet. Biol. 2008, 45, 1404–1414. [Google Scholar] [CrossRef]
  51. Mora-Montes, H.M.; McKenzie, C.; Bain, J.M.; Lewis, L.E.; Erwig, L.P.; Gow, N.A. Interactions between macrophages and cell wall oligosaccharides of Candida albicans. Methods Mol. Biol. 2012, 845, 247–260. [Google Scholar]
  52. Mora-Montes, H.M.; Netea, M.G.; Ferwerda, G.; Lenardon, M.D.; Brown, G.D.; Mistry, A.R.; Kullberg, B.J.; O’Callaghan, C.A.; Sheth, C.C.; Odds, F.C.; et al. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect. Immun. 2011, 79, 1961–1970. [Google Scholar] [CrossRef] [PubMed]
  53. Graham, L.M.; Tsoni, S.V.; Willment, J.A.; Williams, D.L.; Taylor, P.R.; Gordon, S.; Dennehy, K.; Brown, G.D. Soluble Dectin-1 as a tool to detect beta-glucans. J. Immunol. Methods 2006, 314, 164–169. [Google Scholar] [CrossRef] [PubMed]
  54. Perez-Garcia, L.A.; Csonka, K.; Flores-Carreon, A.; Estrada-Mata, E.; Mellado-Mojica, E.; Nemeth, T.; Lopez-Ramirez, L.A.; Toth, R.; Lopez, M.G.; Vizler, C.; et al. Role of protein glycosylation in Candida parapsilosis cell wall integrity and host interaction. Front. Microbiol. 2016, 7, 306. [Google Scholar] [CrossRef] [PubMed]
  55. De Nobel, J.G.; Klis, F.M.; Munnik, T.; Priem, J.; Van Den Ende, H. An assay of relative cell wall porosity in Saccharomyces cerevisiae, Kluyveromyces lactis and Schizosaccharomyces pombe. Yeast 1990, 6, 483–490. [Google Scholar] [CrossRef] [PubMed]
  56. Hobson, R.P.; Munro, C.A.; Bates, S.; MacCallum, D.M.; Cutler, J.E.; Heinsbroek, S.E.; Brown, G.D.; Odds, F.C.; Gow, N.A. Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition. J. Biol. Chem. 2004, 279, 39628–39635. [Google Scholar] [CrossRef] [PubMed]
  57. Smolenski, G.; Sullivan, P.A.; Cutfield, S.M.; Cutfield, J.F. Analysis of secreted aspartic proteinases from Candida albicans: Purification and characterization of individual Sap1, Sap2 and Sap3 isoenzymes. Microbiology 1997, 143, 349–356. [Google Scholar] [CrossRef] [PubMed]
  58. Mora-Montes, H.M.; Lopez-Romero, E.; Zinker, S.; Ponce-Noyola, P.; Flores-Carreon, A. Hydrolysis of Man9GlcNAc2 and Man8GlcNAc2 oligosaccharides by a purified alpha-mannosidase from Candida albicans. Glycobiology 2004, 14, 593–598. [Google Scholar] [CrossRef]
  59. Papp, C.; Kocsis, K.; Tóth, R.; Bodai, L.; Willis, J.R.; Ksiezopolska, E.; Lozoya-Pérez, N.E.; Vágvölgyi, C.; Mora Montes, H.; Gabaldón, T.; et al. Echinocandin-induced microevolution of Candida parapsilosis influences virulence and abiotic stress tolerance. mSphere 2018, 3, e00518–e00547. [Google Scholar] [CrossRef]
  60. Peeters, E.; Nelis, H.J.; Coenye, T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J. Microbiol. Methods 2008, 72, 157–165. [Google Scholar] [CrossRef]
  61. Pierce, C.G.; Thomas, D.P.; López-Ribot, J.L. Effect of tunicamycin on Candida albicans biofilm formation and maintenance. J. Antimicrob. Chemother. 2009, 63, 473–479. [Google Scholar] [CrossRef]
  62. Al-Fattani, M.A.; Douglas, L.J. Biofilm matrix of Candida albicans and Candida tropicalis: Chemical composition and role in drug resistance. J. Med. Microbiol. 2006, 55, 999–1008. [Google Scholar] [CrossRef] [PubMed]
  63. Lima, O.C.; Figueiredo, C.C.; Pereira, B.A.; Coelho, M.G.; Morandi, V.; Lopes-Bezerra, L.M. Adhesion of the human pathogen Sporothrix schenckii to several extracellular matrix proteins. Braz. J. Med. Biol. Res. 1999, 32, 651–657. [Google Scholar] [CrossRef] [PubMed]
  64. Endres, S.; Ghorbani, R.; Lonnemann, G.; van der Meer, J.W.; Dinarello, C.A. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin. Immunol. Immunopathol. 1988, 49, 424–438. [Google Scholar] [CrossRef] [PubMed]
  65. Tamez-Castrellón, A.K.; van der Beek, S.L.; López-Ramírez, L.A.; Martínez-Duncker, I.; Lozoya-Pérez, N.E.; van Sorge, N.M.; Mora-Montes, H.M. Disruption of protein rhamnosylation affects the Sporothrix schenckii-host interaction. Cell Surf. 2021, 7, 100058. [Google Scholar] [CrossRef] [PubMed]
  66. Clavijo-Giraldo, D.M.; Matinez-Alvarez, J.A.; Lopes-Bezerra, L.M.; Ponce-Noyola, P.; Franco, B.; Almeida, R.S.; Mora-Montes, H.M. Analysis of Sporothrix schenckii sensu stricto and Sporothrix brasiliensis virulence in Galleria mellonella. J. Microbiol. Methods 2016, 122, 73–77. [Google Scholar] [CrossRef] [PubMed]
  67. García-Carnero, L.C.; Clavijo-Giraldo, D.M.; Gómez-Gaviria, M.; Lozoya-Pérez, N.E.; Tamez-Castrellón, A.K.; López-Ramírez, L.A.; Mora-Montes, H.M. Early virulence predictors during the Candida species-Galleria mellonella interaction. J. Fungi 2020, 6, 152. [Google Scholar] [CrossRef]
  68. Loibl, M.; Strahl, S. Protein O-mannosylation: What we have learned from baker’s yeast. Biochim. Biophys. Acta Mol. Cell Res. 2013, 1833, 2438–2446. [Google Scholar] [CrossRef]
  69. Marakalala, M.J.; Vautier, S.; Potrykus, J.; Walker, L.A.; Shepardson, K.M.; Hopke, A.; Mora-Montes, H.M.; Kerrigan, A.; Netea, M.G.; Murray, G.I.; et al. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog. 2013, 9, e1003315. [Google Scholar] [CrossRef]
  70. Levin, D.E. Regulation of cell wall biogenesis in Saccharomyces cerevisiae: The cell wall integrity signaling pathway. Genetics 2011, 189, 1145–1175. [Google Scholar] [CrossRef]
  71. Dichtl, K.; Samantaray, S.; Wagener, J. Cell wall integrity signalling in human pathogenic fungi. Cell Microbiol. 2016, 18, 1228–1238. [Google Scholar] [CrossRef]
  72. Martín, H.; Molina, M. Special issue “The Fungal Cell Wall Integrity Pathway”. J. Fungi 2023, 9, 293. [Google Scholar] [CrossRef] [PubMed]
  73. Lin, C.J.; Wu, C.Y.; Yu, S.J.; Chen, Y.L. Protein kinase A governs growth and virulence in Candida tropicalis. Virulence 2018, 9, 331–347. [Google Scholar] [CrossRef] [PubMed]
  74. Contreras Martínez, O.I.; Angulo Ortíz, A.; Santafé Patiño, G.; Peñata-Taborda, A.; Berrio Soto, R. Isoespintanol antifungal activity involves mitochondrial dysfunction, inhibition of biofilm formation, and damage to cell wall integrity in Candida tropicalis. Int. J. Mol. Sci. 2023, 24, 10187. [Google Scholar] [CrossRef] [PubMed]
  75. Ramos Lde, S.; Barbedo, L.S.; Braga-Silva, L.A.; dos Santos, A.L.; Pinto, M.R.; Sgarbi, D.B. Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis. Rev. Iberoam. Micol. 2015, 32, 122–125. [Google Scholar] [CrossRef] [PubMed]
  76. Staniszewska, M. Virulence factors in Candida species. Curr. Protein Pept. Sci. 2020, 21, 313–323. [Google Scholar] [CrossRef] [PubMed]
  77. Lim, S.J.; Mohamad Ali, M.S.; Sabri, S.; Muhd Noor, N.D.; Salleh, A.B.; Oslan, S.N. Opportunistic yeast pathogen Candida spp.: Secreted and membrane-bound virulence factors. Med. Mycol. 2021, 59, 1127–1144. [Google Scholar] [CrossRef] [PubMed]
  78. Gantner, B.N.; Simmons, R.M.; Underhill, D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. Embo J. 2005, 24, 1277–1286. [Google Scholar] [CrossRef]
  79. Smith, A.J.; Graves, B.; Child, R.; Rice, P.J.; Ma, Z.; Lowman, D.W.; Ensley, H.E.; Ryter, K.T.; Evans, J.T.; Williams, D.L. Immunoregulatory activity of the natural product laminarin varies widely as a result of its physical properties. J. Immunol. 2018, 200, 788–799. [Google Scholar] [CrossRef]
  80. Gómez-Gaviria, M.; Lozoya-Pérez, N.E.; Staniszewska, M.; Franco, B.; Niño-Vega, G.A.; Mora-Montes, H.M. Loss of Kex2 affects the Candida albicans cell wall and interaction with innate immune cells. J. Fungi 2020, 6, 57. [Google Scholar] [CrossRef]
  81. Zuza-Alves, D.L.; Silva-Rocha, W.P.; Chaves, G.M. An update on Candida tropicalis based on basic and clinical approaches. Front. Microbiol. 2017, 8, 1927. [Google Scholar] [CrossRef]
  82. Butler, G.; Rasmussen, M.D.; Lin, M.F.; Santos, M.A.S.; Sakthikumar, S.; Munro, C.A.; Rheinbay, E.; Grabherr, M.; Forche, A.; Reedy, J.L.; et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 2009, 459, 657–662. [Google Scholar] [CrossRef] [PubMed]
  83. Queiroz, S.S.; Jofre, F.M.; Bianchini, I.A.; Boaes, T.D.S.; Bordini, F.W.; Chandel, A.K.; Felipe, M. Current advances in Candida tropicalis: Yeast overview and biotechnological applications. Biotechnol. Appl. Biochem. 2023, 70, 2069–2087. [Google Scholar] [CrossRef] [PubMed]
  84. de Souza, C.M.; Dos Santos, M.M.; Furlaneto-Maia, L.; Furlaneto, M.C. Adhesion and biofilm formation by the opportunistic pathogen Candida tropicalis: What do we know? Can. J. Microbiol. 2023, 69, 207–218. [Google Scholar] [CrossRef] [PubMed]
  85. Gómez-Gaviria, M.; Ramírez-Sotelo, U.; Mora-Montes, H.M. Non-albicans Candida species: Immune response, evasion mechanisms, and new plant-derived alternative therapies. J. Fungi 2022, 9, 11. [Google Scholar] [CrossRef] [PubMed]
  86. Lussier, M.; Gentzsch, M.; Sdicu, A.M.; Bussey, H.; Tanner, W. Protein O-glycosylation in yeast. The PMT2 gene specifies a second protein O-mannosyltransferase that functions in addition to the PMT1-encoded activity. J. Biol. Chem. 1995, 270, 2770–2775. [Google Scholar] [CrossRef]
  87. Willger, S.D.; Ernst, J.F.; Alspaugh, J.A.; Lengeler, K.B. Characterization of the PMT gene family in Cryptococcus neoformans. PLoS ONE 2009, 4, e6321. [Google Scholar] [CrossRef]
  88. Girrbach, V.; Strahl, S. Members of the evolutionarily conserved PMT family of protein O-mannosyltransferases form distinct protein complexes among themselves. J. Biol. Chem. 2003, 278, 12554–12562. [Google Scholar] [CrossRef] [PubMed]
  89. Strahl-Bolsinger, S.; Gentzsch, M.; Tanner, W. Protein O-mannosylation. Biochim. Biophys. Acta 1999, 1426, 297–307. [Google Scholar] [CrossRef]
  90. Cantero, P.D.; Ernst, J.F. Damage to the glycoshield activates PMT-directed O-mannosylation via the Msb2-Cek1 pathway in Candida albicans. Mol. Microbiol. 2011, 80, 715–725. [Google Scholar] [CrossRef]
  91. Peltroche-Llacsahuanga, H.; Goyard, S.; d’Enfert, C.; Prill, S.K.; Ernst, J.F. Protein O-mannosyltransferase isoforms regulate biofilm formation in Candida albicans. Antimicrob. Agents Chemother. 2006, 50, 3488–3491. [Google Scholar] [CrossRef]
  92. Kozik, A.; Karkowska-Kuleta, J.; Zajac, D.; Bochenska, O.; Kedracka-Krok, S.; Jankowska, U.; Rapala-Kozik, M. Fibronectin-, vitronectin- and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic yeasts. BMC Microbiol. 2015, 15, 197. [Google Scholar] [CrossRef] [PubMed]
  93. Corbucci, C.; Cenci, E.; Skrzypek, F.; Gabrielli, E.; Mosci, P.; Ernst, J.F.; Bistoni, F.; Vecchiarelli, A. Immune response to Candida albicans is preserved despite defect in O-mannosylation of secretory proteins. Med. Mycol. 2007, 45, 709–719. [Google Scholar] [CrossRef]
  94. Heinsbroek, S.E.; Taylor, P.R.; Martinez, F.O.; Martinez-Pomares, L.; Brown, G.D.; Gordon, S. Stage-specific sampling by pattern recognition receptors during Candida albicans phagocytosis. PLoS Pathog. 2008, 4, e1000218. [Google Scholar] [CrossRef] [PubMed]
  95. Rouabhia, M.; Schaller, M.; Corbucci, C.; Vecchiarelli, A.; Prill, S.K.; Giasson, L.; Ernst, J.F. Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases. Infect. Immun. 2005, 73, 4571–4580. [Google Scholar] [CrossRef] [PubMed]
  96. Wächtler, B.; Wilson, D.; Haedicke, K.; Dalle, F.; Hube, B. From attachment to damage: Defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS ONE 2011, 6, e17046. [Google Scholar] [CrossRef] [PubMed]
Figure 1. A guide tree constructed with Candida albicans PMT family members and putative orthologs on Candida tropicalis. The amino acid sequences of C. albicans PMT family members, along with the putative orthologs identified in C. tropicalis, were downloaded from (http://www.candidagenome.org/, accessed on 30 April 2024), used in multiple sequence alignments in Clustal Omega (https://www.ebi.ac.uk/jdispatcher/msa/clustalo, accessed on 30 April 2024), and from this, the guide tree was constructed. Labels starting with Ca are C. albicans sequences, whilst those beginning with CTRG are from C. tropicalis.
Figure 1. A guide tree constructed with Candida albicans PMT family members and putative orthologs on Candida tropicalis. The amino acid sequences of C. albicans PMT family members, along with the putative orthologs identified in C. tropicalis, were downloaded from (http://www.candidagenome.org/, accessed on 30 April 2024), used in multiple sequence alignments in Clustal Omega (https://www.ebi.ac.uk/jdispatcher/msa/clustalo, accessed on 30 April 2024), and from this, the guide tree was constructed. Labels starting with Ca are C. albicans sequences, whilst those beginning with CTRG are from C. tropicalis.
Jof 10 00502 g001
Figure 2. Complementation of Candida albicans PMT2/pmt2∆ heterozygous mutant with Candida tropicalis CTRG_05668. In (A), yeasts were incubated in YPD broth added with different concentrations of Congo red, calcofluor white, or hygromycin B and incubated for 24 h at 30 °C, and growth was measured by absorbance at 600 nm. Data are shown as a percentage of fungal growth in culture with no perturbing agent added. Data are means ± SD of three independent experiments performed in duplicates. The curves generated with the heterozygous mutant or the pmt6∆ null mutants were significantly different from those generated with the WT control strain or the heterozygous mutant complemented with CTRG_05668 (p < 0.05 when compared by two-way ANOVA). In (B), colony morphology after 5 days at 30 °C on Spider medium. Scale bars, 1 mm. Strains used are NGY152 (WT), HMY211 (PMT2/pmt2Δ), HMY212 (PMT2/pmt2Δ + CTRG_05668), HMY213 (pmt6Δ), and HMY214 (pmt6Δ + CTRG_05668).
Figure 2. Complementation of Candida albicans PMT2/pmt2∆ heterozygous mutant with Candida tropicalis CTRG_05668. In (A), yeasts were incubated in YPD broth added with different concentrations of Congo red, calcofluor white, or hygromycin B and incubated for 24 h at 30 °C, and growth was measured by absorbance at 600 nm. Data are shown as a percentage of fungal growth in culture with no perturbing agent added. Data are means ± SD of three independent experiments performed in duplicates. The curves generated with the heterozygous mutant or the pmt6∆ null mutants were significantly different from those generated with the WT control strain or the heterozygous mutant complemented with CTRG_05668 (p < 0.05 when compared by two-way ANOVA). In (B), colony morphology after 5 days at 30 °C on Spider medium. Scale bars, 1 mm. Strains used are NGY152 (WT), HMY211 (PMT2/pmt2Δ), HMY212 (PMT2/pmt2Δ + CTRG_05668), HMY213 (pmt6Δ), and HMY214 (pmt6Δ + CTRG_05668).
Jof 10 00502 g002
Figure 3. The Candida tropicalis pmt2∆ null mutant fails to undergo dimorphism. Yeast cells grown in RPMI 1640 supplemented with 2.5% (v/v) fetal calf serum for 3.5 h at 37 °C. Scale bars 10 µm. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 3. The Candida tropicalis pmt2∆ null mutant fails to undergo dimorphism. Yeast cells grown in RPMI 1640 supplemented with 2.5% (v/v) fetal calf serum for 3.5 h at 37 °C. Scale bars 10 µm. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g003
Figure 4. Cell wall analysis of Candida tropicalis wild-type, pmt2∆, and reintegrant control strains. In (A), cell walls were acid hydrolyzed and monosaccharides were analyzed by high-performance anion-exchange chromatography with pulsed amperometric detection. In (B), cell walls were alkali-hydrolyzed and used to quantify cell wall protein content with a colorimetric method. In (C), cell walls were trimmed with endoglycosidase H or β-elimination, releasing N-linked or O-linked mannans, respectively. The free glycans were quantified and data were normalized to 109 yeasts. In (D), yeasts were incubated with fluorescein isothiocyanate conjugated wheat germ agglutinin or IgG Fc-dectin-1 chimera and anti-Fc IgG-fluorescein isothiocyanate specific lectins to label either chitin or β-1,3-glucan, respectively, and the fluorescence of 300 cells was estimated. Data are shown as mean ± SD of three independent experiments performed in duplicate. * p < 0.05 when compared to WT, or reintegrant control strain. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 4. Cell wall analysis of Candida tropicalis wild-type, pmt2∆, and reintegrant control strains. In (A), cell walls were acid hydrolyzed and monosaccharides were analyzed by high-performance anion-exchange chromatography with pulsed amperometric detection. In (B), cell walls were alkali-hydrolyzed and used to quantify cell wall protein content with a colorimetric method. In (C), cell walls were trimmed with endoglycosidase H or β-elimination, releasing N-linked or O-linked mannans, respectively. The free glycans were quantified and data were normalized to 109 yeasts. In (D), yeasts were incubated with fluorescein isothiocyanate conjugated wheat germ agglutinin or IgG Fc-dectin-1 chimera and anti-Fc IgG-fluorescein isothiocyanate specific lectins to label either chitin or β-1,3-glucan, respectively, and the fluorescence of 300 cells was estimated. Data are shown as mean ± SD of three independent experiments performed in duplicate. * p < 0.05 when compared to WT, or reintegrant control strain. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g004
Figure 5. Susceptibility to Congo red, calcofluor white, and hygromycin B in the Candida tropicalis pmt2∆. Yeasts were incubated in YPD added with different concentrations of Congo red, calcofluor white, or hygromycin B; plates incubated for 24 h at 30 °C; and cell growth was measured by reading absorbance at 600 nm. Results are shown as a percentage of those obtained with control cultures were no perturbing agent was included. The same strain grown in the absence of any perturbing agent corresponds to 100%. Data are means ± SD of three independent experiments performed in duplicates. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 5. Susceptibility to Congo red, calcofluor white, and hygromycin B in the Candida tropicalis pmt2∆. Yeasts were incubated in YPD added with different concentrations of Congo red, calcofluor white, or hygromycin B; plates incubated for 24 h at 30 °C; and cell growth was measured by reading absorbance at 600 nm. Results are shown as a percentage of those obtained with control cultures were no perturbing agent was included. The same strain grown in the absence of any perturbing agent corresponds to 100%. Data are means ± SD of three independent experiments performed in duplicates. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g005
Figure 6. Analysis of Candida tropicalis adhesion to extracellular matrix components by ELISA. The extracellular matrix proteins were used to coat 96-well plates, yeasts were added to the plates, nonadherent cells were washed, and adhesion was detected with anti-Candida polyclonal antibodies and peroxidase-conjugated anti-rabbit IgG. Results are means ± SD of three independent experiments performed in duplicate. * p < 0.05 when compared to wild-type (WT) strain. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 6. Analysis of Candida tropicalis adhesion to extracellular matrix components by ELISA. The extracellular matrix proteins were used to coat 96-well plates, yeasts were added to the plates, nonadherent cells were washed, and adhesion was detected with anti-Candida polyclonal antibodies and peroxidase-conjugated anti-rabbit IgG. Results are means ± SD of three independent experiments performed in duplicate. * p < 0.05 when compared to wild-type (WT) strain. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g006
Figure 7. Cytokine stimulation in human peripheral blood mononuclear cells. In (A), yeast and human cells were co-incubated at 37 °C for 24 h, and the secreted cytokines were quantified by ELISA. * p < 0.05 when compared to wild-type (WT) strain.  p < 0.05 when compared to untreated cells. In (B), human cells were preincubated with 200 μg mL−1 laminarin before the interactions with yeasts. HK: heat-killed cells. * p < 0.05 when compared to WT strain. ** p < 0.05 when compared to live yeasts.  p < 0.05 when compared to untreated cells. Data are means ± SD obtained with samples from eight donors, assayed in duplicate wells. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 7. Cytokine stimulation in human peripheral blood mononuclear cells. In (A), yeast and human cells were co-incubated at 37 °C for 24 h, and the secreted cytokines were quantified by ELISA. * p < 0.05 when compared to wild-type (WT) strain.  p < 0.05 when compared to untreated cells. In (B), human cells were preincubated with 200 μg mL−1 laminarin before the interactions with yeasts. HK: heat-killed cells. * p < 0.05 when compared to WT strain. ** p < 0.05 when compared to live yeasts.  p < 0.05 when compared to untreated cells. Data are means ± SD obtained with samples from eight donors, assayed in duplicate wells. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g007
Figure 8. Phagocytosis of Candida tropicalis by human monocyte-derived macrophages. In (A), yeasts and human monocyte-derived macrophages were co-incubated at 37 °C for 2 h and 5% (v/v) CO2 and fungal uptake were analyzed by flow cytometry. Depending on the positivity in the different detection channels, human cells interacting with at least one yeast were classified as in phagocytosis’s early, intermediate, and late stages. In (B), similar experiments as those described in (A) were performed but human cells were preincubated with 200 µg mL−1 laminarin for 1 h at 37 °C. Here, only cells in the late stage of phagocytosis were plotted. * p < 0.05 when compared to wild-type (WT) cells.  p < 0.05 when compared to untreated cells. Results are shown as mean ± SD with samples from eight donors analyzed in duplicate. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 8. Phagocytosis of Candida tropicalis by human monocyte-derived macrophages. In (A), yeasts and human monocyte-derived macrophages were co-incubated at 37 °C for 2 h and 5% (v/v) CO2 and fungal uptake were analyzed by flow cytometry. Depending on the positivity in the different detection channels, human cells interacting with at least one yeast were classified as in phagocytosis’s early, intermediate, and late stages. In (B), similar experiments as those described in (A) were performed but human cells were preincubated with 200 µg mL−1 laminarin for 1 h at 37 °C. Here, only cells in the late stage of phagocytosis were plotted. * p < 0.05 when compared to wild-type (WT) cells.  p < 0.05 when compared to untreated cells. Results are shown as mean ± SD with samples from eight donors analyzed in duplicate. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g008
Figure 9. The Candida tropicalis pmt2∆ null mutant shows virulence attenuation in Galleria mellonella larvae. Larva groups, containing 30 individuals were inoculated with 2.0 × 107 yeasts of the corresponding strain, and mortality was recorded daily. PBS refers to a larva group inoculated only with PBS, the vehicle used to prepare fungal inoculums. Data are shown in Kaplan–Meier plots. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Figure 9. The Candida tropicalis pmt2∆ null mutant shows virulence attenuation in Galleria mellonella larvae. Larva groups, containing 30 individuals were inoculated with 2.0 × 107 yeasts of the corresponding strain, and mortality was recorded daily. PBS refers to a larva group inoculated only with PBS, the vehicle used to prepare fungal inoculums. Data are shown in Kaplan–Meier plots. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2).
Jof 10 00502 g009
Table 2. Analysis of the Candida tropicalis PMT family member expression in different growing conditions.
Table 2. Analysis of the Candida tropicalis PMT family member expression in different growing conditions.
StrainPMT1PMT2PMT4PMT5PMT6
YPD a
Wild-type1.0 ± 0.23.3 ± 0.42.4 ± 0.60.8 ± 0.30.6 ± 0.3
pmt20.9 ± 0.4N.D. d2.8 ± 0.30.9 ± 0.50.5 ± 0.4
pmt2∆ + PMT20.9 ± 0.33.1 ± 0.32.6 ± 0.70.6 ± 0.40.5 ± 0.4
SC b
Wild-type1.6 ± 0.42.9 ± 0.43.9 ± 0.70.9 ± 0.51.1 ± 0.5
pmt21.8 ± 0.3N.D.4.2 ± 0.81.1 ± 0.50.8 ± 0.4
pmt2∆ + PMT21.8 ± 1.62.6 ± 0.54.0 ± 0.91.0 ± 0.60.9 ± 0.5
RPMI + FCS c
Wild-type2.4 ± 0.45.2 ± 0.65.2 ± 0.91.1 ± 0.23.1 ± 0.4
pmt22.6 ± 0.5N.D.4.9 ± 0.81.4 ± 0.43.5 ± 0.6
pmt2∆ + PMT22.2 ± 0.55.0 ± 0.55.3 ± 1.11.0± 0.53.0 ± 0.5
The ACT1 gene was used for data normalization. Data are means ± SD of three independent experiments performed in duplicate. a Cells were grown at 28 °C for 24 h. b Cells were grown at 28 °C for 48 h. c Cells were grown for 3.5 h at 37 °C. d Not detected.
Table 3. Gene expression analysis and secreted enzyme activity in Candida tropicalis wild-type, pmt2∆, and reintegrant control strains.
Table 3. Gene expression analysis and secreted enzyme activity in Candida tropicalis wild-type, pmt2∆, and reintegrant control strains.
StrainPKC1 aMKC1 aSecreted Protease (U) bSecreted Lipase (U) c
Wild-type1.2 ± 0.51.0 ± 0.31122.4 ± 223.4395.5 ± 66.5
pmt23.8 ± 0.8 *4.6 ± 0.6 *589.5 ± 179.6 *99.2 ± 49.7 *
pmt2∆ + PMT21.0 ± 0.41.3 ± 0.51098.2 ± 186.4402.5± 63.0
a The ACT1 gene was used for data normalization. b Units defined as the change in absorbance at 280 nm per minute. c Units defined as nmoles 4-methylumbelliferone generated per minute. Data are means ± SD of three independent experiments performed in duplicate. * p < 0.05 when compared to wild-type or pmt2∆ + PMT2 strains.
Table 4. Biofilm formation and analysis of the extracellular matrix in Candida tropicalis wild-type, pmt2∆, and reintegrant control strains.
Table 4. Biofilm formation and analysis of the extracellular matrix in Candida tropicalis wild-type, pmt2∆, and reintegrant control strains.
StrainBiofilm Formation aCFU
(×107 cells) b
Glucose
(µg mL−1) c
Glucosamine
(µg mL−1) c
Protein
(µg mL−1) c
Wild-type4.1 ± 0.21.4 ± 0.640.4 ± 6.2563.8 ± 45.665.5 ± 9.8
pmt22.7 ± 0.2 *0.9 ± 0.2 *18.5 ± 5.6 *265.6 ± 33.5 *22.8 ± 15.6 *
pmt2∆ + PMT24.0 ± 0.31.5 ± 0.337.7 ± 86.4532.6 ± 33.861.5 ± 11.6
a Biofilm formation was assessed by measuring crystal violet reduction at 590 nm. b Colony-forming units (CFUs) were calculated after biofilms were incubated with chitinase for cell detachment from wells. c Quantified from cell-free biofilm preparations obtained with chitinase. Data are means ± SD of three independent experiments performed in duplicate. * p < 0.05 when compared to wild-type or pmt2∆ + PMT2 strains.
Table 5. Colony-forming units, cytotoxicity, hemocyte, melanin, and phenoloxidase levels in Galleria mellonella larvae inoculated with Candida tropicalis.
Table 5. Colony-forming units, cytotoxicity, hemocyte, melanin, and phenoloxidase levels in Galleria mellonella larvae inoculated with Candida tropicalis.
StrainCFUs (×107) aCytotoxicity
(%) b
Hemocytes (×106)
mL−1
Melanin cPhenoloxidase d
PBS e0.0 ± 0.09.8 ± 4.25.4 ± 0.41.1 ± 0.20.3 ± 0.1
WT1.3 ± 0.478.9 ± 9.62.2 ± 0.54.2 ± 0.42.9 ± 0.3
pmt21.4 ± 0.326.4 ± 11.5 *4.9 ± 0.2 *2.3 ± 0.5 *1.1 ± 0.2 *
pmt2∆ + PMT21.3 ± 0.581.2 ± 15.42.5 ± 0.64.4 ± 0.23.2 ± 0.6
a Hemolymph was collected from decapitated larvae and used to quantify the colony-forming units (CFUs) by serial dilutions in YPD plates. b Lactate dehydrogenase activity was quantified in cell-free hemolymph. Data are normalized to a positive control (lysed hemocytes) that corresponds to 100% activity. c Measured in the cell-free hemolymph at A405nm. d Phenoloxidase activity defined as the Δ490nm min−1 μg protein −1. e Larvae inoculated only with PBS. Strains used are MYA-3404 (WT), HMY218 (pmt2Δ), and HMY220 (pmt2Δ + PMT2). * p < 0.05 when compared with WT strain.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hernández-Chávez, M.J.; Martínez-Duncker, I.; Clavijo-Giraldo, D.M.; López-Ramirez, L.A.; Mora-Montes, H.M. Candida tropicalis PMT2 Is a Dispensable Gene for Viability but Required for Proper Interaction with the Host. J. Fungi 2024, 10, 502. https://doi.org/10.3390/jof10070502

AMA Style

Hernández-Chávez MJ, Martínez-Duncker I, Clavijo-Giraldo DM, López-Ramirez LA, Mora-Montes HM. Candida tropicalis PMT2 Is a Dispensable Gene for Viability but Required for Proper Interaction with the Host. Journal of Fungi. 2024; 10(7):502. https://doi.org/10.3390/jof10070502

Chicago/Turabian Style

Hernández-Chávez, Marco J., Iván Martínez-Duncker, Diana M. Clavijo-Giraldo, Luz A. López-Ramirez, and Héctor M. Mora-Montes. 2024. "Candida tropicalis PMT2 Is a Dispensable Gene for Viability but Required for Proper Interaction with the Host" Journal of Fungi 10, no. 7: 502. https://doi.org/10.3390/jof10070502

APA Style

Hernández-Chávez, M. J., Martínez-Duncker, I., Clavijo-Giraldo, D. M., López-Ramirez, L. A., & Mora-Montes, H. M. (2024). Candida tropicalis PMT2 Is a Dispensable Gene for Viability but Required for Proper Interaction with the Host. Journal of Fungi, 10(7), 502. https://doi.org/10.3390/jof10070502

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop